Remove Programs Remove Safety Remove Treatment
article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

A team of Israeli researchers conducted a randomized placebo-controlled clinical trial to assess the safety and efficacy of a novel, metered-dose cannabis inhaler in 27 patients with chronic pain. Chronic pain is the most commonly reported qualifying condition among medical cannabis patients enrolled in state-specific access programs.

article thumbnail

Virginia: New Medical Cannabis Laws Take Effect July 1

NORML

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “This year, my focus was on program improvements to further expand both access and therapeutic value to benefit the health and well-being of all Virginians.” SCHOOL-USE.

Law 262
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Oregon is Setting the Foundation for its Psilocybin Therapy Program

Veriheal

The first legal psilocybin therapy program to take shape in America is slowly progressing in Oregon. Kate Brown conducts regularly scheduled monthly meetings with a goal of shaping the nation’s first Psilocybin therapy program. Oregon’s Psilocybin Therapy Program: Advisory Board Hard at Work. What is Psilocybin?

Therapy 98
article thumbnail

Michigan Cannabis Industry Must Be Prepared for Environmental, Health, and Safety Compliance Inspections from EGLE and MIOSHA

Dykema (Cannabis Law Blog)

As the Michigan cannabis industry continues to grow and mature, medical and adult-use licensees would be well served to take proactive steps to ensure compliance with Environmental, Health and Safety (EHS) regulations.

article thumbnail

4 Reasons Why Total Count Microbial Tests Are Poor Safety Indicators

Medicinal Genomics

The truth is that total count tests are not a good indicator of cannabis and hemp product safety for the following reasons: Pathogenic microbes may still be present Testing methods often do not agree Growers are discouraged from using beneficial microbes Growers are encouraged to use remediation. fumigatus, A.

Safety 92
article thumbnail

Weekly Legislative Roundup 2/22/20

NORML

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. The bill would allow qualifying patients to access all the alternative treatment centers instead of having to designate just one.

article thumbnail

Bipartisan Bill To Protect Employment Rights

NORML

Enacted in 1986, the Federal Drug-Free Workplace Program made it a condition for employment that all civilian employees at executive branch agencies be prohibited from using federally illegal substances on or off duty. ” Changes in the legal status of marijuana at the state level have not negatively impacted workplace safety.